Pharmaceutically Assisted Angioplasty to Relieve Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage-A Retrospective, Single-Center, Observational Comparison of Established and New Treatment Techniques. [PDF]
Thole C, Maurer CJ, Berlis A.
europepmc +1 more source
Protocol for an open-label, randomised, controlled trial to evaluate the efficacy and safety of sotatercept add-on therapy compared with pulmonary vasodilator-based standard of care for pulmonary vasodilator-resistant pulmonary arterial hypertension associated with unrepaired congenital shunts (atrial septal defect, ventricular septal defect or patent ductus arteriosus), including Eisenmenger syndrome: the SuMILE trial. [PDF]
Yoshida K +19 more
europepmc +1 more source
Comparative Efficacy and Safety of Vasodilators Used to Prevent Internal Thoracic Artery Spasm in Coronary Artery Bypass Grafting: A Systematic Review. [PDF]
Qaiser Aziz Khan M +4 more
europepmc +1 more source
Treatment Paradigm Shifts in Pulmonary Arterial Hypertension: Evidence From Asia on Vasodilators to Antiremodeling Therapies. [PDF]
Wen W, Cao Y.
europepmc +1 more source
Awake Flexible Scope Intubation in Critically Ill Patients With Physiologically Difficult Airways: A Prospective, Observational Case Series. [PDF]
Camiré DCD +3 more
europepmc +1 more source
Transient Aortic Vasospasm Case Report-The "Triple Adrenal" Sign. [PDF]
Katz A, DeMaio A, Frech P, Dunn DP.
europepmc +1 more source
Impact of the 2017 ACC/AHA hypertension guidelines on antihypertensive prescribing in the United States: real-world evidence from a nationally representative population. [PDF]
Jafari EA.
europepmc +1 more source
Could Lipo-Prostaglandin E1 Be the Key to Improving Success Rates in Free-Flap Microsurgery? A Systematic Review. [PDF]
AlQhtani A.
europepmc +1 more source
Decoding the coronary paradox of obesity: not all fat is equal! [PDF]
Santulli G, Pande S, Mone P, Varzideh F.
europepmc +1 more source
Pulmonary Veno-Occlusive Disease: A Comprehensive Review of Diagnostic Challenges, Therapeutic Limitations, and Evolving Management. [PDF]
Foster B +3 more
europepmc +1 more source

